Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pennant GroupPNTG +3.34%88 Debt-to-EBITDA is 5.73 as of Mar. 2026, which is 57% below its 10-year median of 13.39. GuruFocus rates PNTG with a GF Score™ of 88/100 and a GF Value™ of $34.91 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Pennant Group ranks worse than 83.86% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Pennant Group's Debt-to-EBITDA or its related term are showing as below:
PNTG'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 6.15 Med: 13.39 Max: 37.57
Current: 6.85
During the past 10 years, the highest Debt-to-EBITDA Ratio of Pennant Group was 37.57. The lowest was 6.15. And the median was 13.39.
PNTG's Debt-to-EBITDA is ranked worse than 83.86% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs PNTG: 6.85
Pennant Group (NAS:PNTG) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Pennant Group Debt-to-EBITDA Related Terms
Pennant Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Pennant Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PNTG vs AMN, NUTX, ARDT: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Pennant Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Pennant Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Pennant Group (PNTG) has a Debt-to-EBITDA of 5.73 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Pennant Group. This is 57% below median its historical median of 13.39. Over the past decade, Pennant Group's Debt-to-EBITDA has ranged from 6.15 to 37.57. According to the industry distribution chart, Pennant Group ranks #400 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 83.9%.
Is Pennant Group's Debt-to-EBITDA too high?
Pennant Group's current Debt-to-EBITDA of 5.73 is 57% below median its 10-year median of 13.39. Over the past 10 years, this metric has ranged from a low of 6.15 to a high of 37.57. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. Pennant Group's value of 5.73 is 158.1% above this industry median. Based on the distribution chart, Pennant Group ranks #400 out of 477 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pennant Group has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's Debt-to-EBITDA compare to AMN and NUTX?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #400 out of 477 companies for Debt-to-EBITDA. This places Pennant Group in the lower half of its industry. The industry median Debt-to-EBITDA is 2.22. Pennant Group's value of 5.73 is 158.1% above this benchmark. Historically, Pennant Group's own Debt-to-EBITDA has ranged from 6.15 to 37.57 over the past decade. While the company's 10-year median is 13.39 vs. the industry median of 2.22, Pennant Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current Debt-to-EBITDA of 5.73 is 158.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Pennant Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current Debt-to-EBITDA is 5.73, which is 57% below median its own 10-year median of 13.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $34.91, compared to a current price of $41.16 — trading 17.9% above its estimated fair value. The current Debt-to-EBITDA is 5.73, which is 57% below median its 10-year median of 13.39 and 158.1% above the Healthcare Providers & Services industry median of 2.22. Pennant Group's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Pennant Group (PNTG), the current Debt-to-EBITDA is 5.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $41.16 is trading 17.9% above its estimated GF Value™ of $34.91.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
Debt-to-EBITDA: 5.73 (57% below median its 10-year median of 13.39)
GF Value™: $34.91 vs. price of $41.16 (17.9% above fair value)
Industry Position: 158.1% above the Healthcare Providers & Services median (#400 of 477)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
88GF Score
Get the complete analysis for PNTG
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
